Serina Therapeutics, Inc. — Director's Dealing 2021

Feb 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AgeX Therapeutics, Inc. (AGE)
CIK: 0001708599
Period of Report: 2021-02-05

Reporting Person: Juvenescence Ltd (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-05	Warrant to Purchase Common Stock	$1.895	P	263852	Acquired	2024-01-25	Common Stock (263852)	Direct

Footnotes

F1: Warrants issued in connection with the draw of loan funds under a Secured Convertible Facility Agreement between the issuer and the reporting person.

F2: The warrants are exercisable for shares of the issuer's common stock upon issuance.